...
search icon
cert-img

Certara Inc, Common Stock

CERT

NSQ

$14.03

+$0

(0%)

1D
Industry: Health Care Technology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.26B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.58M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.57
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$9.41 L
$19.87 H
$14.03

About Certara Inc, Common Stock

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey. more

Industry: Health Care TechnologySector: Health Care

Returns

Time FrameCERTSectorS&P500
1-Week Return2.71%0.36%1.35%
1-Month Return11.26%2.7%1.42%
3-Month Return42%3.64%3.61%
6-Month Return13.15%-4.84%9.32%
1-Year Return-19.04%0.84%23.18%
3-Year Return-39.6%15.06%42.39%
5-Year Return-63.16%40.67%80.85%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue243.53M286.10M335.64M354.34M354.34M[{"date":"2020-12-31","value":68.73,"profit":true},{"date":"2021-12-31","value":80.74,"profit":true},{"date":"2022-12-31","value":94.72,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue100.77M111.62M132.58M141.02M141.02M[{"date":"2020-12-31","value":71.45,"profit":true},{"date":"2021-12-31","value":79.15,"profit":true},{"date":"2022-12-31","value":94.01,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit142.76M174.49M203.07M213.31M213.31M[{"date":"2020-12-31","value":66.93,"profit":true},{"date":"2021-12-31","value":81.8,"profit":true},{"date":"2022-12-31","value":95.2,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin58.62%60.99%60.50%60.20%60.20%[{"date":"2020-12-31","value":96.12,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.2,"profit":true},{"date":"2023-12-31","value":98.71,"profit":true},{"date":"2024-12-31","value":98.71,"profit":true}]
Operating Expenses167.19M160.91M170.55M254.09M254.09M[{"date":"2020-12-31","value":65.8,"profit":true},{"date":"2021-12-31","value":63.33,"profit":true},{"date":"2022-12-31","value":67.12,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(24.89M)13.58M32.52M(40.77M)(40.77M)[{"date":"2020-12-31","value":-76.52,"profit":false},{"date":"2021-12-31","value":41.75,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-125.38,"profit":false},{"date":"2024-12-31","value":-125.38,"profit":false}]
Total Non-Operating Income/Expense(51.06M)(33.79M)(31.54M)(36.86M)-[{"date":"2020-12-31","value":-5105700000,"profit":false},{"date":"2021-12-31","value":-3379100000,"profit":false},{"date":"2022-12-31","value":-3153900000,"profit":false},{"date":"2023-12-31","value":-3686000000,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income(50.18M)(3.38M)18.75M(55.14M)(55.14M)[{"date":"2020-12-31","value":-267.56,"profit":false},{"date":"2021-12-31","value":-18,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-294.02,"profit":false},{"date":"2024-12-31","value":-294.02,"profit":false}]
Income Taxes(784.00K)9.89M4.02M214.00K214.00K[{"date":"2020-12-31","value":-7.93,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":40.68,"profit":true},{"date":"2023-12-31","value":2.16,"profit":true},{"date":"2024-12-31","value":2.16,"profit":true}]
Income After Taxes(49.40M)(13.27M)14.73M(55.36M)-[{"date":"2020-12-31","value":-335.33,"profit":false},{"date":"2021-12-31","value":-90.05,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-375.79,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(49.40M)(13.27M)14.73M(33.73M)-[{"date":"2020-12-31","value":-335.33,"profit":false},{"date":"2021-12-31","value":-90.05,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-228.95,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(49.40M)(13.27M)14.73M(55.36M)(55.36M)[{"date":"2020-12-31","value":-335.33,"profit":false},{"date":"2021-12-31","value":-90.05,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-375.79,"profit":false},{"date":"2024-12-31","value":-375.79,"profit":false}]
EPS (Diluted)0.070.170.460.440.30[{"date":"2020-12-31","value":16.22,"profit":true},{"date":"2021-12-31","value":36.96,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":95.65,"profit":true},{"date":"2024-12-31","value":65.22,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CERT
Cash Ratio 1.90
Current Ratio 2.86

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CERT
ROA (LTM) 0.59%
ROE (LTM) -2.95%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CERT
Debt Ratio Lower is generally better. Negative is bad. 0.32
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.68

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CERT
Trailing PE NM
Forward PE 27.86
P/S (TTM) 6.06
P/B 2.14
Price/FCF 266
EV/R 6.26
EV/Ebitda 42.18

FAQs

What is Certara Inc share price today?

Certara Inc (CERT) share price today is $14.03

Can Indians buy Certara Inc shares?

Yes, Indians can buy shares of Certara Inc (CERT) on Vested. To buy Certara Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CERT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Certara Inc be purchased?

Yes, you can purchase fractional shares of Certara Inc (CERT) via the Vested app. You can start investing in Certara Inc (CERT) with a minimum investment of $1.

How to invest in Certara Inc shares from India?

You can invest in shares of Certara Inc (CERT) via Vested in three simple steps:

  • Click on Sign Up or Invest in CERT stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Certara Inc shares
What is Certara Inc 52-week high and low stock price?

The 52-week high price of Certara Inc (CERT) is $19.87. The 52-week low price of Certara Inc (CERT) is $9.41.

What is Certara Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Certara Inc (CERT) is 2.14

What is the Market Cap of Certara Inc?

The market capitalization of Certara Inc (CERT) is $2.26B

What is Certara Inc’s stock symbol?

The stock symbol (or ticker) of Certara Inc is CERT

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top